Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 22, 2014
Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma
Matthew M Ladra, Jackie D Szymonifka, Anita Mahajan, et al.
Pediatric Blood & Cancer
|
May 17, 2013
Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy
Alison M Friedmann, Julie A Wolfson, Melissa M Hudson, et al.
Cancer
|
June 16, 2018
Quality of life in patients with proton-treated pediatric medulloblastoma: Results of a prospective assessment with 5-year follow-up
Sophia C Kamran, Saveli I Goldberg, Karen A Kuhlthau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2004
Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease
Melissa M Hudson, Matthew Krasin, Michael P Link, et al.
Blood Advances
|
May 13, 2026
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosis
Barbara A Degar, Oussama Abla, Patrick K Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2019
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331
Kelly W Maloney, Meenakshi Devidas, Cindy Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2021
Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation
Monika L Metzger, Michael P Link, Amy L Billett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2021
Favorable Trisomies and <i>ETV6-RUNX1</i> Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331
Leonard A Mattano, Meenakshi Devidas, Kelly W Maloney, et al.
Cancers
|
February 13, 2026
Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma After Autologous Stem Cell Transplant and External Beam Radiotherapy
Mathew Lin, Jie Jane Chen, Rochelle Bagatell, et al.
The Oncologist
|
April 27, 2021
Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma
Lucas R Massoth, Yin P Hung, Judith A Ferry, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 22, 2014
Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma
Matthew M Ladra, Jackie D Szymonifka, Anita Mahajan, et al.
Pediatric Blood & Cancer
|
May 17, 2013
Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy
Alison M Friedmann, Julie A Wolfson, Melissa M Hudson, et al.
Cancer
|
June 16, 2018
Quality of life in patients with proton-treated pediatric medulloblastoma: Results of a prospective assessment with 5-year follow-up
Sophia C Kamran, Saveli I Goldberg, Karen A Kuhlthau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2004
Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease
Melissa M Hudson, Matthew Krasin, Michael P Link, et al.
Blood Advances
|
May 13, 2026
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosis
Barbara A Degar, Oussama Abla, Patrick K Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2019
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331
Kelly W Maloney, Meenakshi Devidas, Cindy Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2021
Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation
Monika L Metzger, Michael P Link, Amy L Billett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2021
Favorable Trisomies and <i>ETV6-RUNX1</i> Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331
Leonard A Mattano, Meenakshi Devidas, Kelly W Maloney, et al.
Cancers
|
February 13, 2026
Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma After Autologous Stem Cell Transplant and External Beam Radiotherapy
Mathew Lin, Jie Jane Chen, Rochelle Bagatell, et al.
The Oncologist
|
April 27, 2021
Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma
Lucas R Massoth, Yin P Hung, Judith A Ferry, et al.
Page
of 9